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ABSTRACT  
 
Worldwide pharmaceutical companies are restructuring themselves; merger and acquisition have become the 
order of the day. There are more than 25000 pharmaceuticals firms, most of them are very small even larger 
ones have also not been conducting regular market surveys. 
This study provides highly valuable information for determining their future marketing mix and business 
policies.  There is (1) Large number of formulators and bulk drugs manufacturers for each molecule at lowest 
prices vis-à-vis rest of the world (2) Presence of a large number of propaganda firms. Therefore, a study of this 
kind to study the practices and priorities and to visualise likely changes in these is most imperative at this 
juncture. 
It was found by the researcher that ratio of the products of the propaganda concerns is high in prescriptions these 
days. The prescriptions of the ethical companies are dominating in pharma market with seventy percentage 
market share. Researcher also found that almost twenty five market share was captured by propaganda 
companies which favours that ratio of the products of the propaganda concerns is high in prescriptions these 
days. This study also discussed  that ratio of the products of the propaganda concerns is high in the prescriptions 
these days as the maximum number of respondents were in favour of the view that 41-50 percent portion of 
medicine were free from propaganda firms. Mostly chemists have responded positively to maintaining relations 
with doctor. Government practitioners are dominating in prescription. There are 20-40 percent of unnecessary 
drug in prescription by doctors. This research will certainly help pharmaceutical industry to work more on 
research and development area.  
Keywords: Molecules, Drug, Brand, Pharmaceutical, Prescription, Medical practitioners 
 
1. INTRODUCTION 
The pharmaceutical industry plays a crucial role in the well-being of the country by formulating quality 
medicines. Increasing competition, a change market scenario and customer profile, increasing awareness 
amongst and users the Indian pharmaceutical industry is undergoing a metamorphosis. Worldwide 
pharmaceutical companies are restructuring themselves; merger and acquisition have become the order of the 
day. There are more than 25000 pharmaceuticals firms, most of them are very small even larger ones have also 
not been conducting regular market surveys. Therefore this study provides highly valuable information for 
determining their future marketing mix and business policies.  There is (1) Large number of formulators and 
bulk drugs manufacturers for each molecule at lowest prices vis-à-vis rest of the world (2) Presence of a large 
number of propaganda firms. Therefore, a study of this kind to study the practices and priorities and to visualise 
likely changes in these is most imperative at this juncture. Alexander Tsai, "The study of Doctors, 
Pharmaceutical Companies differs in priorities (fwd)", www. mailto.act2@po.cwru.edu., Drug Directorate of 
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Health, Canada, et.al.:, “The study of Physician Prescribing Practices”, Doctor Libby Roughead, "The Study of 
Pharmaceutical Representative and Medical Practitioner Encounter: Implications for quality use of medicines", 
Project Timelines, Dr. R.K. Shrivastav, "A Study of New ethical dimensions in pharma marketing The 
Pharmaceutical Journal Vol 264 No. 7092 p 574 April   1000   Clinical,   "A study of Prescribing Expensive 
Medicines”, were some of the studies conducted to find out the opinion of chemists for pharma companies.  
2. MATERIALS & METHODS 
2.1    Objectives: The proposed study aims at the following: 
 To Study the Performance of Brands and Molecules in the Eyes of Chemists 
 To Study the Frequency (Ratio) of Propaganda and Ethical pharma Companies 
 
2.2    Hypotheses: This study is primarily an exploratory work.  
H1  Criteria for selling a specified brand for particular chemical molecule in most of the cases is the 
corporate goodwill of the manufacturers. 
H2       Ratio of the products of the propaganda's concerns is high in the prescriptions.  
2.3   Sources of Information:   Primary Sources: Chemists 
Table 1: Area Wise Distribution of the Chemists 
Area No. of Chemists Percentage 
Urban 50 
 
50% 
 
Semiurban 30 30% 
Rural 20 20% 
Total 100 100 % 
 
Figure 1: Area Wise Distributions of the Chemists 
Semi Urban
20%
Rural
30%
Urban
50%
 
From table 1 it can be observed that a majority 50 (50 percent) of chemists were from urban area, and 30 (30 
percent) chemist respondents were from rural area, while 20 (20 percent) of chemist respondents were from 
semi urban areas. Interpretation reveals that a majority of 80 percent chemists respondents were from urban and 
semi urban areas while only 20 ( 20 percent) of chemists respondents were from rural areas. 
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3. RESULT & DISCUSSION 
3.4 Drug Brand and Molecule Sales in the opinion of Chemist:  
3.4.1     Performance of molecules brands and companies in the opinion of chemists. 
3.4.2     Perceptions of chemists regarding companies and prescriptions 
 
3.4.1 Performance of Molecules, Brands and Companies in the Opinion of Chemists: Chemists are the 
persons who sell the medicines to the buyers on the basis of physicians' prescription. They are very 
good source of information on performance of various brands available in the market and which brand 
is doing well in that particular area.  
3.4.1(a) Frequency of Preference of Major Brands: Chemist opinion regarding brand of major salts having 
maximum sales from their counter has been studied.  
Table 2: Most Preferred Brands of Major Salts 
 
S. No. Name of Brand Name of Company Average Score Rank 
1. 
 
EES -400 
 
Abott 
 
1.95 
 
XVIII 
 
2. 
 
Lanso-30 
 
Acron 
 
1.75 
 
XXI 
 
3. 
 
Aero spar 
 
Acron 
 
1.95 
 
XVIII 
 
4. 
 
Acmox 
 
Acron 
 
2.20 
 
XVI 
 
5. 
 
Azithral 
 
Alembic 
 
1.80 
 
XX 
 
6. 
 
Sparta 
 
Alembic 
 
2.30 
 
XVI 
 
7. 
 
Nimegesic 
 
Alembic 
 
3.20 
 
V 
 
8. 
 
Althrocin 
 
Alembic 
 
3.50 
 
II 
 
9. 
 
Broadiclox 
 
Alkem 
 
1.85 
 
XIX 
 
10. 
 
Omperaz 
 
Alkem 
 
2.60 
 
XIII 
 
11. 
 
Alcipro 
 
Alkem 
 
2.80 
 
X 
 
12. 
 
Throx 
 
Alkem 
 
2.10 
 
VI 
 
13. 
 
Roxen 
 
Aristo 
 
2.40 
 
XV 
 
14. 
 
Aristozyl 
 
Aristo 
 
2.80 
 
X 
 
15. 
 
Combiflam 
 
Aventis 
 
3.60 
 
I 
 
16. 
 
Beslofen 
 
B.E, 
 
1.80 
 
XX 
 
17. 
 
Ampilox 
 
Biochem 
 
2.20 
 
XVI 
 
18. 
 
Roxibest 
 
Blue cross 
 
2.20 
 
XVI 
 
19. 
 
Cebran 
 
Bluecross 
 
2.60 
 
XIII 
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20. 
 
Symbiotic 
 
Cadila 
 
2.85 
 
IX 
 
21 
 
Acloc 
 
Cadila 
 
1.35 
 
XXIII 
 
22. 
 
Synclar 
 
Cipla 
 
2.40 
 
XV 
 
23. 
 
Amlopress-AT 
 
Cipla 
 
2.50 
 
xrv 
 
24. 
 
Oflox 
 
Cipla 
 
2.60 
 
XIII 
 
25. 
 
Ibugesic 
 
Cipla 
 
2.60 
 
XIII 
 
26. Norflox 
 
Cipla 
 
2.80 
 
X 
 
27. 
 
Amlopress 
 
Cipla 
 
2.90 
 
VIII 
 
28. 
 
Cefadur 
 
Cipla 
 
2.90 
 
VIII 
 
29. 
 
Novaclox 
 
Cipla 
 
3.10 
 
VI 
 
30. 
 
Ciplox 
 
Cipla 
 
3.20 
 
V 
 
31. 
 
Novamox 
 
Cipla 
 
3.60 
 
I 
 
32. 
 
Nise 
 
Dr.Reddy 
 
3.40 
 
III 
 
33. 
 
Omez 
 
Dr.Reddy 
 
3.50 
 
II 
 
34. 
 
Ciprolet 
 
Dr.Reddy 
 
2.90 
 
VIII 
 
35. 
 
Celex 
 
Glaxo 
 
2.60 
 
XIII 
 
36. 
 
Betnesol 
 
Glaxo 
 
2.80 
 
X 
 
37. 
 
Phexin 
 
Glaxo 
 
3.20 
 
V 
 
38. 
 
Betnovate 
 
Glaxo 
 
3.60 
 
I 
 
39. 
 
Candid 
 
Glenmark 
 
3.40 
 
III 
 
40. 
 
Flucort 
 
Grace well 
 
2.60 
 
XIII 
 
 
It has been found from the table 2 research that respondents have ranked various brands as preferences among 
various groups of salts. Respondents have ranked Mox, Ciplox, Odoxil, Corvadil, Doxy-1, Omez, Rantac, 
Conibiilam, Diclovin Plus, Nise, Dexona, Candid and Betnovate etc. as first preference among brands of various 
salts in various groups. Respondents have ranked brands of various companies. Cipla has scored first, Ranbaxy 
has scored second, Torrent has scored third, Zydus Cadila has scored third, Alkem, Alembic and Glaxo all have 
scored fourth etc. Respondents have ranked one propaganda company Acron for fifth position. 
It has been found that almost all respondent have said that all companies which wants to increase their sales, are 
providing various schemes on their product like some companies are providing ten percent and some twenty 
percent schemes, besides these pharma companies are also providing gifts and other items like diaries and 
calendars to chemists. It has been found that if respondents are getting something from that company then 
definitely they do their best to increase the sales of that particular company. In the research respondents were 
asked regarding efforts they are doing to increase the sales of any particular company. It has been found that for 
generic pharma companies from which they are getting good schemes, better profit margin, and respondents are 
putting their best efforts like counter pushing of the product and substitution of the product. It has been found 
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that from ethical pharma companies, respondents are getting ten to twenty percent schemes on whatever product 
respondents are not substituting that product of that particular company. It has been found that respondents, if 
getting adjustments on product by medical representative of any particular company then definitely they put 
their best efforts to increase the sales of that particular company. 
It has been found that almost all respondents have named generic pharma companies for maximum profit 
margin. It has been found that respondents are getting a margin of sixty to seventy percent from generic pharma 
companies. It has been found that respondents are getting ten to twenty percent profit margins from ethical 
companies. There are some exceptions also from which respondents are getting more margins than other 
companies and if schemes on various products are included then respondents are getting more profit margins 
from ethical pharma companies. It has been found that propaganda pharma companies are not giving enough 
profit margins to respondents. 
 
3.4.1(b) Maximum Sales Having Brands on Counter: There are some brands having maximum sales on 
chemist counter. There arc various brands available in the market but some brands are doing very well as 
compare to other brands has been studied.  
Table 3: Brands Giving Maximum Sales 
S. No. 
 
Name of Brand 
 
Name of Company 
 
No. of 
Respondents 
 
Rank 
 
1. 
 
Althrocin 
 
Alembic 
 
8 
 
IV 
 
2. 
 
Nimegesic 
 
Alembic 
 
3 
 
IX 
 
3. Flexon 
 
Aristo 
 
7 
 
V 
 
4. 
 
Megapen 
 
Aristo 
 
3 
 
IX 
 
5. 
 
Allegra 
 
Aventis 
 
2 
 
X 
 
6. 
 
Avil 
 
Aventis 
 
3 
 
IX 
 
7. 
 
Combiflam 
 
Aventis 
 
9 
 
III 
 
8. 
 
Daonil 
 
Aventis 
 
4 
 
VIII 
 
9. 
 
Soframycin 
 
Aventis 
 
5 
 
VII 
 
10. 
 
Cipcal 
 
Cipla 
 
1 
 
XI 
 
11. 
 
Ciplox 
 
Cipla 
 
3 
 
IX 
 
12. 
 
Novamox 
 
Cipla 
 
3 
 
IX 
 
13. 
 
Nise 
 
Dr.Reddy 
 
5 
 
VII 
 
14. 
 
Omez 
 
Dr.Reddy 
 
4 
 
VIII 
 
15. 
 
Dexorange 
 
FrankoIndia 
 
3 
 
IX 
 
16. 
 
Deriphyllin 
 
German remedies 
 
2 
 
X 
 
17. 
 
Betnesol 
 
Glaxo 
 
2 
 
X 
 
18. 
 
Betnovate 
 
Glaxo 
 
1 
 
XI 
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19. 
 
Zentac 
 
Glaxo 
 
4 
 
VIII 
 
20. 
 
Llv-52 
 
Himalayan 
 
8 
 
IV 
 
21. 
 
Cozy Plus 
 
Indswift 
 
3 
 
IX 
 
22. 
 
Aten 
 
Kopran 
 
2 
 
X 
 
23. 
 
Amlovas 
 
Macleods 
 
1 
 
XI 
 
24. 
 
Voveran 
 
Novartis 
 
12 
 
I 
 
25. 
 
Amlogard 
 
Pfizer 
 
1 
 
XI 
 
26. 
 
Becosules Caps 
 
Pfizer 
 
12 
 
I 
 
27. 
 
Corex 
 
Pfizer 
 
9 
 
III 
 
28. 
 
Dolonex-DT 
 
Pfizer 
 
3 
 
IX 
 
29. 
 
Protinex 
 
Pfizer 
 
4 
 
VIII 
 
30. 
 
Cifran 
 
Ranbaxy 
 
3 
 
IX 
 
31. 
 
Mox 
 
Ranbaxy 
 
10 
 
II 
 
32. 
 
Crocin 
 
Smithkline 
 
4 
 
VIII 
 
33. 
 
Quintor 
 
Torrent 
 
2 
 
X 
 
34. 
 
Dynapar 
 
Troikka 
 
2 
 
X 
 
35. 
 
Buscopan 
 
TTK 
 
1 
 
XI 
 
36. 
 
Corvadil 
 
Unichem 
 
5 
 
VII 
 
37. 
 
Trika 
 
Unichem 
 
7 
 
V 
 
38. 
 
Metrogyl 
 
Unique 
 
2 
 
X 
 
39. 
 
Betadine 
 
Win 
 
3 
 
IX 
 
40. 
 
Dicloivin Plus 
 
Wings 
 
8 
 
IV 
 
 
From table 3 in the research respondents were asked regarding maximum sale of brands. Respondents have 
named various brands, some of them are very popular brands .It has been found that Voveran has scored first, 
Becosules Caps has scored first, and Mox has scored second. Combiflam has scored third, Folivite has scored 
fourth, Trika has scored fifth, and Flexon has also scored fifth, were among the brands having maximum sales 
from the respondent's counter. Other brands are also there ranked for maximum sales from the counter. It has 
been Hound that brand from various companies have been ranked by respondent. Respondents have ranked 
brands of some companies for more than one time. Pfizer and Aventis have scored first. Cipla and Glaxo has 
scored second, Wockliardt has scored third etc. 
3.4.1(c) Maximum Sales Having Companies on Counter: Some companies doing very well on chemist 
counter. Major pharmaceutical firms as well as smaller pharma companies are performing well on counter. 
Chemists are also pushing products.  
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Table 4: Maximum Sales Having Companies: Chemists' Perception 
S. No. 
Name of Company No. of Respondents Percent Rank 
1. Cipla Ethical / Generic 25 25% I 
2. 
 
Sun 
 
15 
 
15% 
 
II 
 
3. 
 
Acron 
 
10 
 
10% 
 
in 
 
4. 
 
Intas 
 
10 
 
10% 
 
in 
 
5. 
 
Pfizer 
 
10 
 
10% 
 
in 
 
6. 
 
Aristo 
 
5 
 
5% 
 
IV 
 
7. 
 
Alkem 
 
5 
 
5% 
 
IV 
 
8. 
 
Glaxo 
 
5 
 
5% 
 
IV 
 
9. 
 
Moko 
 
5 
 
5% 
 
IV 
 
10. 
 
Morepen 
 
5 
 
5% 
 
IV 
 
11. 
 
Cadila 
 
5 
 
5% 
 
IV 
 
Figure 2: Maximum Sales Having Companies Chemists' Perception 
25%
15%
10% 10% 10%
5% 5% 5% 5% 5% 5%
0%
5%
10%
15%
20%
25%
Ci
pla Su
n
Ac
ro
n
In
ta
s
Pf
ize
r
Ar
ist
o
Al
ke
m
Gl
ax
o
M
ok
o
M
or
ep
en
Ca
dil
a
Percentage
 
From the table 4 twenty five percent respondents have named Cipla ethical and generic as first company for 
maximum sales from their counter. Sun has scored second with fifteen percent respondents, Pfizer, and Intas has 
scored third with ten percent respondents, propoganda companies like Acron has scored third, and Moko has 
scored fourth. Respondents also named both propaganda pharmaceutical firms for maximum sales from their 
counter. 
3.4.1(d) Most Popular Brands of Major Salts on Counter: There are some salts which are very common for 
practitioners. Practitioners are prescribing various brands of these salts. Some brands are very popular of these 
major salts.  
Table 5: Most Popular Brands of Major Salts 
Group 1 - Amoxycillin 
S. No. 
 
Name of Brand 
 
Name of Company 
 
Average Score 
 
Rank 
 (a) 
 
Mox 
 
Ranbaxy 
 
2.3 
 
I 
 
(b) 
 
Wymox 
 
Wyeth Lederle 
 
1.6 
 
II 
 
(c) 
 
Acmox 
 
Acron 
 
0.95 
 
III 
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Group 2 - Ciprofloxacin 
S No. 
 
Name of Brand 
 
Name of Company 
 
Average Score 
 
Rank 
 
(a) 
 
Ciplox 
 
Cipla 
 
1.95 
 
I 
 
(b) 
 
Alcipro 
 
Alkem 
 
1.40 
 
II 
 
(c) 
 
Quintor 
 
Torrent 
 
1,30 
 
III 
 
 
Group 3 -Cefadroxil 
S. No. 
 
Name of Brand 
 
Name of Company 
 
Average Score 
 
Rank 
 
(a) 
 
Cefadaur 
 
Cipla 
 
1.75 
 
I 
 
(b) 
 
Odoxil 
 
Lupin 
 
1.55 
 
II 
 
(c) 
 
Cefadrox 
 
Aristo 
 
1.2 
 
III 
 
 
Group 4 - Doxycycline 
S. No. 
 
Name of Brand 
 
Name of Company 
 
Average Score 
 
Rank 
 (a) 
 
Doxy- 1 
 
U.S.V. 
 
2.25 
 
I 
 
(b) 
 
Doxypal-DR 
 
Jagsonpal 
 
1.55 
 
II 
 
(c) 
 
Doxyric 
 
Euphoric 
 
1.3 
 
III 
 
 
Group 5 - Norfloxacin 
S.No. 
 
Name of Brand 
 
Name of Company 
 
Average Score 
 
Rank 
 
(a) 
 
Norflox 
 
Cipla 
 
2.85 
 
I 
 
(b) 
 
Norbactin 
 
Ranbaxy 
 
2.70 
 
II 
 
(c) 
 
Uroflox 
 
Torrent 
 
2.60 
 
III 
  
Group 6 - Amoxy + Cloxacillin 
S. NO. 
 
Name of Brand 
 
Name of Company 
 
Average Score 
 
Rank 
 (a) 
 
Symbiotic 
 
Cadia 
 
2.2 
 
I 
 
(b) 
 
Novaclox 
 
Cipla 
 
2.1 
 
II 
 
(c) 
 
Suprimox 
 
Ranbaxy 
 
1.75 
 
III 
 
 
Group 7 - Amolodipine 
S. NO. 
 
Name of Brand 
 
Name of Company 
 
Average Score 
 
Rank 
 
(a) 
 
Corvadil 
 
Unichem 
 
2.5 
 
I 
 
(b) 
 
Amlopress 
 
Cipla 
 
1.85 
 
II 
 
(c) 
 
Amlovas 
 
Macleods 
 
1.60 
 
III 
 
 
International Journal of Marketing & Financial Management, Volume 5, Issue 5, May-2017,   pp 37-51         
ISSN: 2348 –3954 (Online)    ISSN: 2349 –2546 (Print),   
Contact Us : info@arseam.com ; submit paper :  editor@arseam.com  download full paper :  www.arseam.com                45 
 
Group 8 - Amlodipine + Atenolol 
S. NO. 
 
Name of Brand 
 
Name of Company 
 
Average Score 
 
Rank 
 (a) 
 
Corvadil-A 
 
Unichem 
 
2.3 
 
I 
 
(b) 
 
Amlovas-AT 
 
Macleods 
 
1.90 
 
II 
 
(c) 
 
Amtas-AT 
 
Intas 
 
1.75 
 
III 
 
 
Group 9 – Lossartan Potassium 
S. NO. 
 
Name of Brand 
 
Name of Company 
 
Average Score 
 
Rank 
 (a) 
 
Losacar 
 
Cadila 
 
2.2 
 
I 
 
(b) 
 
Tozzar 
 
Torrent 
 
2.10 
 
II 
 
(c) 
 
Losar 
 
Unichem 
 
1.95 
 
III 
  
Group 10 - Omeprazole 
S. NO. 
 
Name of Brand 
 
Name of Company 
 
Average Score 
 
Rank 
 (a) 
 
Ornez 
 
Dr. Reddy 
 
2.60 
 
I 
 
(b) 
 
Omepraz 
 
Alkem 
 
1.95 
 
II 
 
(c) 
 
Ocid 
 
Zydus Cadila 
 
1.70 
 
III 
 
 
Group 11 -Pantoprazole 
S. NO. 
 
Name of Brand 
 
Name of Company 
 
Average Score 
 
Rank 
 (a) 
 
Pantocid 
 
Sun 
 
2.40 
 
I 
 
(b) 
 
Pantodac 
 
Zydus Cadila 
 
1.80 
 
II 
 
(c) 
 
Pan-40 
 
Alkem 
 
1.20 
 
III 
  
Group 12 - Ibuprofen + Paracetamol 
S. NO. 
 
Name of Brand 
 
Name of Company 
 
Average Score 
 
Rank 
 (a) 
 
Combiflam 
 
Aventis 
 
2.80 
 
I 
 
(b) 
 
Flexon 
 
Aristo 
 
1.85 
 
II 
 
(c) 
 
Be'stofen 
 
Bio.E 
 
1.60 
 
III 
 
 
Group 13 - Diclofenac + Paracetamol 
S. NO. 
 
Name of Brand 
 
Name of Company 
 
Average Score 
 
Rank 
 (a) 
 
Diclovin-Plus 
 
Wings 
 
2.60 
 
I 
 
(b) 
 
Combigesic D.P. 
 
Bal Pharma 
 
2.30 
 
II 
 
(c) 
 
Dicloran-A 
 
Lekar 
 
1.75 
 
III 
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It has been found from table 5 of the research that respondents have named various brands which are most popular and 
have highest sales from their counter.Mox of Ranbaxy has scored first in-group one. Ciplox of Cipla has scored first in 
group two. Cefadur of Cipla has scored first in-group three. Doxy-1 of USV has scored first in fourth groups, Norflox of 
Cipla has secured first in group five, and Symbiotic of Cadila has scored first in group six. Corvadil of Unichem 
has scored first in group seven Corvadil -A of Unichem has scored first in group eight, Losacar of Cadila has scored 
first in group nine, Omez of Dr.Reddy has scored first in group ten, and Pantocid of Sun has scored first in group 
eleven.  
Combiflam of Aventis has scored first in group twelve. Diclovin plus of Wings pharma has scored first in group 
thirteen, Dexona of Zydus cadila has scored first in group fourteen and Betnovate of Glaxo has scored first in group 
fifteen for most popular and highest sales having brands. It has been found that Cipla has scored as first Preference 
Company.  
It has been found from this research that respondents have ranked Cipla for number one company, whose brands 
they prefer most. Unichem, Cadila, Glaxo, Torrent, Alkem, and Aristo etc. are the other companies' respondents 
preferring most. 
 
3.4.2 Perception   of Chemists   Regarding   Companies   and Prescriptions: Chemists have exact 
information regarding which type of company is dominating in prescriptions whether it is ethical, propaganda or 
generic.  
3.4.2(a) Nature of Company Dominating in Prescriptions:  
Table 6: Company Dominating in Prescriptions Chemists' Perception 
S. No. Type of Company No of Respondents Percent Rank 
1. Ethical 70 70% I 
2. Propaganda 25 25% II 
3. Generic 5 5% III 
 
Figure 3: Companies Dominating in Prescriptions Chemists' 
Propaganda
25%
Generic
5%
Ethical
70%
 
From table 6 in this research respondent were asked regarding the type of company dominating in prescription 
by doctors, to test the hypothesis that the ratio of the products of the propaganda concerns is high in the 
prescriptions these days, a direct question was asked to the chemists on companies dominating in 
prescriptions. Twenty five percent of respondents were in favour of above hypothesis. The above ratio 
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occupied by the propaganda firm is very high as far as pharma market is concerned. Seventy-percent 
respondents have named ethical pharma companies for dominating in prescription by doctors. It has been 
found that generic pharma companies are not dominating in prescription by doctors. Only five percent of 
respondents have named generic pharma companies for domination in prescription. Thus the second 
hypothesis is largely proved that the ratio of propaganda products is high in prescription these days. 
3.4.2(b) Brands being Prescribed and their Earlier Ones: There are some brands very popular having 
maximum sales at present, earlier there were some other brands of other companies were doing well. This may 
be because of various reasons.  
Table 7: Brands Currently Prescribed and their Earlier Ones 
S. No. 
 
Currently 
 
Name of Company 
 
5 years 
ago 
 
Name of 
Company 
 
10 years 
ago 
 
Name of 
Company 
 
1 
 
Alcipro 
 
Alkem 
 
Ciprobid 
 
Cadila 
 
Cifran 
 
Ranbaxy 
 
2 
 
Althrocin 
 
Alembic 
 
Etomin 
 
Sun 
 
Eltocin 
 
Ipca 
 
3 
 
Zenflox 
 
Mankind 
 
Tarivid 
 
Aventis 
 
Zanocin 
 
Ranbaxy 
 
4 
 
Acmox 
 
Acron 
 
Mox 
 
Ranbaxy 
 
Wymox 
 
Wyeth 
 
5 
 
Sparlox 
 
Sun 
 
Sparta 
 
Alembic 
 
Scat 
 
Cadila 
 
 
It has been found from the table 7 from this research that respondents have named several brands which are at 
present top selling brands like Alcipro, Althrocin, Zenflox, Acmox, Sparlox, etc., Earlier there were other brands 
as top brands like five years ago Ciprobid and ten years ago Cifran was doing very well. Also in case of 
Ofloxacin brands earlier Tarivid and Zanocin were doing very well but currently other companies brand 
like Zenflox of Mankind is doing well, this may be because of cost of the brand and several other factors. 
3.4.2(c) Chemist Liaison with Practitioners: Chemist and practitioners relations are very important from 
various points of views. In this section of the chapter chemists have given their opinion regarding their relation 
with the practitioners. Chemists have different opinion about maintaining liaison with the doctor.  
Table 8: Maintaining Liaison with Practitioners 
S.No. Response No. of Respondents Percent Rank 
1 Positive 70 70% I 
2 Negative 30 30% II 
 
Figure 4: Maintaining Liaisons with Practitioners 
Negative
30%
Positive
70%
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It has been found from the table 8 that when respondents were asked regarding their liaison with doctors, most 
of the respondents (seventy-percent) responded positively for maintaining liaison with doctors. Out of all 
respondents seventy percent of them believe in maintaining positive relation with doctors. Thirty percent of 
respondents have responded negatively. 
3.4.2(d) Type of Doctors who’s Prescription Comes to Counter: Chemists are the person who has 
information regarding type of doctors whose prescriptions are coming to their counter has been studied in this 
section.  
Table 9: Prescriptions to Counter Chemists' perception 
S. No. Category No. of Respondents Percent Rank 
1 Government Practitioners 60 60% I 
2 Private Practitioners 30 30% II 
3 General Practitioners 10 10% III 
Figure 5: Prescriptions to Counter Chemists' perception 
Private 
Practitioners
30%
General 
Practitioners
10%
Government 
Practitioners
60%
 
From the table 9 in the research respondents were asked regarding type of doctors whose prescription comes to 
their counter. Here type of doctors means whether the doctor is government practitioners, private practitioners or 
general practitioners. It has been found from the research that there are more number of government 
practitioners (sixty percent) in the research area, private practitioners are also there but they are less in 
numbers(thirty percent).General practitioners were only ten percent includes Ayurvedic, and Homeopathic etc. 
3.4.2(e)   Unnecessary Drugs in Prescriptions by Practitioners: There are lot of unnecessary drugs in 
prescriptions by doctors because of various reasons has been already studied in earlier chapters. Chemists have 
information on how many unnecessary drugs in the prescriptions by doctors. It has been studied in this section.  
In this research from the table 10 respondents were asked regarding percent of unnecessary drugs in prescription 
by doctors. It has been found from this research that a major part of respondents have said that there are 31-40 
percent which has scored first, unnecessary drugs in prescription by doctors. 21-30 percent has scored second, in 
unnecessary drug category and 41-50 percent has scored third in unnecessary drugs category. 51-60 percent 
category has scored fourth. Any respondents have not taken 60-100 percent category of unnecessary drugs into 
account. 
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Table 10: Unnecessary Drugs in Prescriptions 
S. No. 
 
Percent of Drugs 
 
Average Score 
 
Rank 
 
1. 
 
31-40 
 
1.60 
 
I 
 
2. 
 
21-30 
 
0.90 
 
II 
 
3. 
 
41-50 
 
0.50 
 
III 
 
4. 
 
51-60 
 
0.30 
 
IV 
 
5. 
 
11-20 
 
0.06 
 
V 
 
6. 
 
0-10 
 
0.05 
 
VI 
 
7. 
 
61-70 
 
0.00 
 
VII 
 
8. 
 
71-80 
 
0.00 
 
VII 
 
9. 
 
81-90 
 
0.00 
 
VII 
 
10. 
 
91-100 
 
0.00 
 
VII 
 
 
3.4.2(f) Prescriptions Free From Propaganda Concern by Practitioners: Chemists have information on 
medicines free from propaganda firms in prescriptions by doctors. It has been studied in this section. Key 
findings are being presented hereunder. 
Table 11: Prescription Free From Propaganda Concern 
S. No. 
 
Percent of Prescriptions 
 
Average Score 
 
Rank 
 
1. 
 
41-50 
 
1.6 
 
I 
 2. 
 
51-60 
 
0.75 
 
II 
 3. 
 
31-40 
 
0.6 
 
III 
 
4. 
 
21-30 
 
0.5 
 
IV 
 5. 
 
61-70 
 
0.35 
 
V 
 6. 
 
11-20 
 
0.1 
 
VI 
 7. 
 
0-10 
 
0.05 
 
VII 
 8. 
 
71-80 
 
0.00 
 
VIII 
 9. 
 
81-90 
 
0.00 
 
VIII 
 10. 
 
91-100 
 
0.00 
 
VIII 
 From table 11: a disguised question on medicines free from propaganda concerns was also framed to collect the 
exact information about the share of propaganda firms in the prescriptions to test the hypothesis that the ratio of 
the products of the propaganda concerns is high in the prescriptions these days. The results of table 6.10 show 
that maximum number of respondents was in favour of the view that 41-50 percent of prescriptions are free 
from propaganda concerns. It means that the rest 50 percent portion was of propaganda concerns the above view 
has achieved first ranked with maximum average score. It has been found that 51-60 percent and 31-40 percent 
has scored second and third respectively. Any respondents have not taken 70-100 percent category into account. 
Thus the fourth hypothesis is again proved. 
Yogesh Jain (2017), “PERFORMANCE OF PHARMA BRANDS, MOLECULES & COMPANIES IN THE EYE OF CHEMISTS” 
Contact Us : info@arseam.com ; submit paper :  editor@arseam.com  download full paper :  www.arseam.com                50 
 
3.4.2 (f) Daily Propaganda Prescriptions to Counter: In this section of the chapter chemist's opinion about 
daily propaganda prescriptions to their counter has been discussed. Nowadays emergence of propaganda firms 
in the market is increasing rapidly. Key findings are being presented hereunder. 
Table 12: Daily Propaganda Prescriptions to Counter 
S. No. 
 
Prescriptions 
 
No. of Respondents 
 
Percent 
 
Rank 
 
1 
 
11-15 
 
40 
 
40% 
 
I 
 2 
 
16-20 
 
30 
 
30% 
 
II 
 3 
 
6-10 
 
20 
 
20% 
 
III 
 4 
 
0-5 
 
10 
 
10% 
 
IV 
 In this research from table 12 when respondents were asked regarding how many propaganda prescriptions 
daily come to their counter. It has been found that from this research that major part of respondents have said 
that 11-15 (forty-percent) prescriptions arc of propaganda firms daily coming to their counters. The results of 
table 12 daily propaganda prescriptions to counter are also favour the fourth hypothesis that the ratio of the 
product of the propaganda concerns is high in prescriptions these days. 
 
4.    CONCLUSION 
 Chemists have ranked various brands as preference among group of salts. Mostly brand belongs to 
Cipla, Ranbaxy, Torrent, Cadila, Alkem, Alembic and Glaxo etc. major pharma companies. 
 Among maximum selling brands Voveran of Novartis, Becosule Caps of Pfizer, Mox of Ranbaxy, 
Corex of Pfizer, Combiflam of Aventies have scored over others. 
 Cipla ethical and generic has scored first. Sun, Intas, Pfizer, Cadila, Morepen were other companies 
giving maximum sales on counter. Apart from ethical firms propaganda concerns like Acron and Moko 
were also there giving maximum sales on counter. 
 In major salts category brands of Cipla company has achieved maximum sales followed by brands of 
Glaxo, Aventies, Dr. Reddy, Unichem, Cadila, USV etc. 
 The prescriptions of the ethical companies are dominating in pharma market with seventy percentage 
market share. As the table 6 shows that twenty five market share was captured by propaganda 
companies which favours the hypothesis that ratio of the products of the propaganda concerns is 
high in prescriptions these days. 
 The results of table 11 also favours the hypothesis that ratio of the products of the propaganda 
concerns is high in the prescriptions these days as the maximum number of respondents were in 
favour of the view that 41-50 percent portion of medicine were free from propaganda firms. 
 Mostly chemists have responded positively to maintaining relations with doctor. Government 
practitioners are dominating in prescription. There are 20-40 percent of unnecessary drug in 
prescription by doctors. 
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